SK Chemicals will jointly carry out development and Phase 3 clinical trial of next generation children enteritis vaccine
SK Chemicals is enlarging its position in the international market with its technology and manufacturing power in vaccine.
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.